You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.6% | 0.6% |
| Div Cover | 8.1 | 8.4 |
| Op Mrgn | 10.9% | 19.6% |
| ROCE | 75.9% |
| Latest | Forecast | |
|---|---|---|
| P/E | 22.3 | 17.5 |
| PEG | 2.2 | 1.1 |
| Price / Revenue | 3.5 | 3.0 |
| Price / Book value | 3.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 26.1% | 9.1% |
| PBT | 154.6% | n/a |
| EPS | 9.9% | -1.1% |
| DPS | 12.0% | 1.4% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | 126.64 | 21.24 | 24.50p | 15.4 | 1.5 | 10% | 3.10p | 0.8% |
| 2015-06-30 | 184.40 | 8.30 | 28.00p | 22.3 | 1.6 | 14% | 3.40p | 0.5% |
| 2016-06-30 | 339.90 | 15.90 | 33.40p | 18.1 | 0.9 | 19% | 4.00p | 0.7% |
| 2017-06-30 | 302.30 | 14.10 | 41.30p | 20.8 | 0.9 | 24% | 5.00p | 0.6% |
| 2018-06-30 | 381.20 | 35.90 | 45.40p | 20.2 | 2.0 | 10% | 5.60p | 0.6% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | 454.02 | 89.19 | 53.40p | 17.5 | 1.0 | 18% | 6.33p | 0.7% |
| 2020-06-30 | 537.03 | 129.95 | 76.42p | 12.2 | 0.3 | 43% | 8.14p | 0.9% |
| Clinigen to take back US rights to cancer drugs Sharecast News | 15 May |
|---|---|
| Clinigen monopolises global rights for skin cancer treatment Sharecast News | 02 Apr |
| Clinigen earnings grow following CSM and iQone acquisitions Sharecast News | 27 Feb |
| US commercial rights of Ethyol® and Totect® | 15-May-19 07:05 |
|---|---|
| Clinigen completes US Proleukin rights acquisition | 02-Apr-19 07:03 |
| Grant of share options and PDMR notification | 29-Mar-19 14:40 |
| Half Year Results | 27-Feb-19 07:06 |
| Holding(s) in Company | 25-Feb-19 15:46 |